This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Stemcell Technologies Canada Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Adam Hirst - Innovator in Stem Cell Research
Introduction
Adam Hirst is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of stem cell research, particularly through his innovative patent that enhances the survival and proliferation of stem cells. His work is crucial for advancing medical research and therapies involving stem cells.
Latest Patents
Adam Hirst holds a patent titled "Media and methods for enhancing the survival and proliferation of stem cells." This patent focuses on improved supplements and culture media that enhance the survival or proliferation of mammalian stem cells. Specifically, it highlights the addition of a lipid supplement, such as a lipid-enriched carrier, to the culture medium. This enhancement can increase the survival and/or proliferation of stem cells by at least 5% to 65% compared to culture media without the lipid supplement.
Career Highlights
Adam Hirst is associated with Stemcell Technologies Canada Inc., a company dedicated to providing innovative solutions for stem cell research. His work at this organization has positioned him as a key player in the advancement of stem cell technologies.
Collaborations
Some of his coworkers include Arwen Hunter and Melanie Kardel, who contribute to the collaborative environment at Stemcell Technologies Canada Inc. Their combined efforts help drive forward the research and development of stem cell applications.
Conclusion
Adam Hirst's contributions to stem cell research through his patent and work at Stemcell Technologies Canada Inc. underscore his importance in the field. His innovative approaches are paving the way for future advancements in medical therapies involving stem cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile